StockData
PAVmed Inc. logo

PAVmed Inc. (PAVM) stock

PAVMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$1.51−0.24 (-13.71%)

Close on Nov 17, 2026Market cap $12.07MP/E –Yield –

PAVmed ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

PAVmed's ebitda for the twelve months ending Jun 30, 2026 was -$26.63M. For fiscal 2025 it was -$21.70M. The highest annual figure on record is -$21.70M in fiscal 2025.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$21.70M–
FY2024Dec 31, 2024-$43.29M–
FY2023Dec 31, 2023-$65.86M–
FY2022Dec 31, 2022-$88.63M–
FY2021Dec 31, 2021-$54.17M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$7.00M–
Q1 FY2026Mar 31, 2026-$8.02M–
Q4 FY2025Dec 31, 2025-$6.79M–
Q3 FY2025Sep 30, 2025-$4.82M–
Q2 FY2025Jun 30, 2025-$4.69M–
Q1 FY2025Mar 31, 2025-$5.40M–
Q4 FY2024Dec 31, 2024-$5.12M–
Q3 FY2024Sep 30, 2024-$11.34M–
Q2 FY2024Jun 30, 2024-$13.38M–
Q1 FY2024Mar 31, 2024-$13.45M–
Q4 FY2023Dec 31, 2023-$15.66M–
Q3 FY2023Sep 30, 2023-$14.80M–
Q2 FY2023Jun 30, 2023-$15.74M–
Q1 FY2023Mar 31, 2023-$19.67M–
Q4 FY2022Dec 31, 2022-$23.88M–
Q3 FY2022Sep 30, 2022-$22.67M–
Q2 FY2022Jun 30, 2022-$22.67M–
Q1 FY2022Mar 31, 2022-$19.42M–
Q4 FY2021Dec 31, 2021-$19.51M–
Q3 FY2021Sep 30, 2021-$13.64M–

More PAVmed figures

See a number that looks wrong?